Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

Preventing Long-Term Neurologic Disability in Hemophilia (A): Cost-Effectiveness of Emicizumab Prophylaxis for the Prevention of Intracranial Hemorrhage in Infants with Severe Hemophilia (A)

Samira Glaeser-Khan, Rhys Richmond, Satoko Ito, Robert D Bona, Harlan M. Krumholz, Adam Cuker, George Goshua

Blood (2024) 144 (Supplement 1): 157.

https://doi.org/10.1182/blood-2024-203690

Published: 2024

Journal Articles

Use of Fidanacogene Elaparvovec, a Gene Therapy Vector, to Deliver a Stable, Fully Functional Human Factor IX Transgene for the Treatment of Hemophilia B: A Combined Analysis of Safety

Ben Samelson-Jones, Laurent Frenzel, Kaan Kavakli, Adam Cuker, Jerome M. Teitel, Pengling Sun, Lisa J Wilcox, Francesca Biondo, Benjamin Hutter, John McKay, Delphine Agathon, Frank Plonski

Blood (2024) 144 (Supplement 1): 3577.

https://doi.org/10.1182/blood-2024-193453

Published: 2024

Journal Articles

Critical Bleeding in Adults and Children with Immune Thrombocytopenia: A Multicentre Cohort Study

Blood (2024) 144 (Supplement 1): 547.

https://doi.org/10.1182/blood-2024-210851

Published: 2024

Journal Articles

Cost-Effectiveness of Oral Versus Intravenous First-Line Treatment of Severe Iron Deficiency Anemia in Women with Heavy Menstrual Bleeding

Daniel Wang, Daniel Y Wang, Samira Glaeser-Khan, Ranya Moshashaian Asl, Karthik Chetlapalli, Satoko Ito, Adam Cuker, George Goshua

Blood (2024) 144 (Supplement 1): 281.

https://doi.org/10.1182/blood-2024-198803

Published: 2024

Journal Articles

Sex, Lies, and Iron Deficiency in 2024: Cost-Effectiveness of Screening Ferritin Thresholds for the Treatment of Iron Deficiency in Women of Reproductive Age

Daniel Wang, Samira Glaeser-Khan, Daniel Y Wang, Ranya Moshashaian Asl, Karthik Chetlapalli, Satoko Ito, Adam Cuker, George Goshua

Blood (2024) 144 (Supplement 1): 277.

https://doi.org/10.1182/blood-2024-203654

Published: 2024

Journal Articles

Defining and Developing a Curriculum for Systems-Based Hematology: A Qualitative Thematic Analysis of Expert Interviews

Richard C Godby, Jacob Cogan, Adam Cuker, David Garcia, Ming Y Lim, Camila Masias, Jori E. May, Colleen T. Morton, Jordan K Schaefer, Surbhi Shah, Marc Stuart Zumberg, Ariela L. Marshall

Blood (2024) 144 (Supplement 1): 3820.

https://doi.org/10.1182/blood-2024-194644

Published: 2024

Journal Articles

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Satoko Ito, Karthik Chetlapalli, Daniel Wang, Kunal C Potnis, Rhys Richmond, Harlan Krumholz, Alfred I Lee, Adam Cuker, George Goshua

Blood blood.2024025176.

https://doi.org/10.1182/blood.2024025176

Published: 2024

Includes: Supplemental data

Journal Articles

Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States

Christina Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D. Bona, Adam Cuker, George Goshua

Blood (2024) 143 (22): 2332–2335.

https://doi.org/10.1182/blood.2024024209

Published: 2024

Includes: Supplemental data

Journal Articles

Cost-Effectiveness of Sutimlimab Versus Standard-of-Care in Transfusion Dependent Patients with Primary Cold Agglutinin Disease in the United States

Satoko Ito, Daniel Wang, Adriana Purcell, Karthik Chetlapalli, Alfred I Lee, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 2316.

https://doi.org/10.1182/blood-2023-187270

Published: 2023

Journal Articles

Ianalumab, a Novel Anti-B-Cell Activating Factor (BAFF) Receptor (BAFF-R) Monoclonal Antibody (mAb) in Development for Immune Thrombocytopenia (ITP) and Warm Autoimmune Hemolytic Anemia (wAIHA), Has Demonstrated a Favorable Safety Profile in Sjögren's Syndrome (SjS), Systemic Lupus Erythematosus (SLE) and Chronic Lymphocytic Leukemia (CLL)

Adam Cuker, Hanny Al-Samkari, Wilma Barcellini, Nichola Cooper, Waleed Ghanima, Marc Michel, Raymond SM Wong, Francesco Zaja, Fengkui Zhang, Patrick Urban, Roberto Abi Rached, David J Kuter

Blood (2023) 142 (Supplement 1): 5427.

https://doi.org/10.1182/blood-2023-180055

Published: 2023

Journal Articles

Cost-Effectiveness of Rapid Hemosil Versus in-House and Send-out ADAMTS13 Activity Testing in the Care of Patients with Immune Thrombotic Thrombocytopenic Purpura

Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 368.

https://doi.org/10.1182/blood-2023-184927

Published: 2023

Journal Articles

Cost-Effectiveness of Long-Term Prophylaxis with Plasma-Derived Vs. Recombinant Von Willebrand Factor in Severe Von Willebrand Disease

Christina Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D Bona, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 3698.

https://doi.org/10.1182/blood-2023-188018

Published: 2023

Journal Articles

Examining Postpartum Anticoagulation Practices: An International Survey of Healthcare Providers

Evangelia Vlachodimtropoulou Koumoutsea, A. Kinga Malinowski, Adam Cuker, Eric Kaplovitch, Nadine Shehata

Blood (2023) 142 (Supplement 1): 2643.

https://doi.org/10.1182/blood-2023-177611

Published: 2023

Journal Articles

Treatment of Critical Bleeding Events in Patients with Immune Thrombocytopenia: A Systematic Review

Blood (2023) 142 (Supplement 1): 7239.

https://doi.org/10.1182/blood-2023-179448

Published: 2023

Journal Articles

A Phase III Clinical Trial Program Investigating the Efficacy and Safety of Ianalumab in Patients with Primary Immune Thrombocytopenia (VAYHIT1 and VAYHIT2) and Warm Autoimmune Hemolytic Anemia (VAYHIA)

Hanny Al-Samkari, Wilma Barcellini, Nichola Cooper, Waleed Ghanima, Marc Michel, Raymond SM Wong, Francesco Zaja, Fengkui Zhang, Patrick Urban, Alex Allepuz, Justyna Fronczek-Sokol, Jens Haenig, Pascal Edrich, Adam Cuker

Blood (2023) 142 (Supplement 1): 5456.

https://doi.org/10.1182/blood-2023-180647

Published: 2023

Journal Articles

TPO-RAs and ITP remission: cause or coincidence?

Kristen M. Sanfilippo, Adam Cuker

Blood (2023) 141 (23): 2790–2791.

https://doi.org/10.1182/blood.2023020243

Published: 2023

Journal Articles

Fatigue and Cognition During Remission in Adults with Immune Thrombotic Thrombocytopenic Purpura

Shannon M Reeves, Amanda J Llaneza, Sara K. Vesely, Janna Journeycake, Mohamad O. Khawandanah, Marshall Mazepa, Frank Akwaa, Adam Cuker, Shruti Chaturvedi, Neil Zakai, Ming Yeong Lim, Radhika Gangaraju, San Keller, Spero Cataland, Deirdra R Terrell

Blood (2022) 140 (Supplement 1): 1228–1229.

https://doi.org/10.1182/blood-2022-170139

Published: 2022

Journal Articles

Documentation of Menstrual Concerns in Patients with Inherited Bleeding Disorders

Ximena Tienhoven, Allyson M Pishko, Elaine Chiang, Adam Cuker, Ariela L. Marshall

Blood (2022) 140 (Supplement 1): 13134–13135.

https://doi.org/10.1182/blood-2022-159795

Published: 2022

Journal Articles

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP

Eun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer DiRaimo, Terry Gernsheimer, Alexandra Kruse, Craig Kessler, Caroline Kruse, Andrew D. Leavitt, Alfred I. Lee, Howard A. Liebman, Adrian C. Newland, Ashley E. Ray, Michael D. Tarantino, Jecko Thachil, David J. Kuter, Douglas B. Cines, James B. Bussel

Blood (2022) 139 (10): 1564–1574.

https://doi.org/10.1182/blood.2021013411

Published: 2022

Includes: Supplemental data

Journal Articles

Durability of Platelet Response When Switching from Eltrombopag or Romiplostim to Avatrombopag in Immune Thrombocytopenia (ITP): A Multicenter Study

Hanny Al-Samkari, Debbie Jiang, Terry B. Gernsheimer, Howard A. Liebman, Susie Lee, Chelsea Bernheisel, Scott Kolodny, Matthew Wojdyla, Michael Vredenburg, Brian Jamieson, Adam Cuker

Blood (2021) 138 (Supplement 1): 1015.

https://doi.org/10.1182/blood-2021-151321

Published: 2021

NARROW

Preventing Long-Term Neurologic Disability in Hemophilia (A): Cost-Effectiveness of Emicizumab Prophylaxis for the Prevention of Intracranial Hemorrhage in Infants with Severe Hemophilia (A)

Use of Fidanacogene Elaparvovec, a Gene Therapy Vector, to Deliver a Stable, Fully Functional Human Factor IX Transgene for the Treatment of Hemophilia B: A Combined Analysis of Safety

Critical Bleeding in Adults and Children with Immune Thrombocytopenia: A Multicentre Cohort Study

Cost-Effectiveness of Oral Versus Intravenous First-Line Treatment of Severe Iron Deficiency Anemia in Women with Heavy Menstrual Bleeding

Sex, Lies, and Iron Deficiency in 2024: Cost-Effectiveness of Screening Ferritin Thresholds for the Treatment of Iron Deficiency in Women of Reproductive Age

Defining and Developing a Curriculum for Systems-Based Hematology: A Qualitative Thematic Analysis of Expert Interviews

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States

Cost-Effectiveness of Sutimlimab Versus Standard-of-Care in Transfusion Dependent Patients with Primary Cold Agglutinin Disease in the United States

Cost-Effectiveness of Rapid Hemosil Versus in-House and Send-out ADAMTS13 Activity Testing in the Care of Patients with Immune Thrombotic Thrombocytopenic Purpura

Cost-Effectiveness of Long-Term Prophylaxis with Plasma-Derived Vs. Recombinant Von Willebrand Factor in Severe Von Willebrand Disease

Examining Postpartum Anticoagulation Practices: An International Survey of Healthcare Providers

Treatment of Critical Bleeding Events in Patients with Immune Thrombocytopenia: A Systematic Review

A Phase III Clinical Trial Program Investigating the Efficacy and Safety of Ianalumab in Patients with Primary Immune Thrombocytopenia (VAYHIT1 and VAYHIT2) and Warm Autoimmune Hemolytic Anemia (VAYHIA)

TPO-RAs and ITP remission: cause or coincidence?

Fatigue and Cognition During Remission in Adults with Immune Thrombotic Thrombocytopenic Purpura

Documentation of Menstrual Concerns in Patients with Inherited Bleeding Disorders

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP

Durability of Platelet Response When Switching from Eltrombopag or Romiplostim to Avatrombopag in Immune Thrombocytopenia (ITP): A Multicenter Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only